Advertisement

Topics

Roche's Ocrevus shows earlier, better outcomes in primary progressive and relapsing MS http://bit.ly/2CDUhf1  @Roche #pharmapic.twitter.com/nKuVF6lxFm

08:33 EDT 11 Oct 2018 | Pharmafile

Roche's Ocrevus shows earlier, better outcomes in primary progressive and relapsing MS http://bit.ly/2CDUhf1 

Original Article: Roche's Ocrevus shows earlier, better outcomes in primary progressive and relapsing MS http://bit.ly/2CDUhf1  @Roche #pharmapic.twitter.com/nKuVF6lxFm

NEXT ARTICLE

More From BioPortfolio on "Roche's Ocrevus shows earlier, better outcomes in primary progressive and relapsing MS http://bit.ly/2CDUhf1  @Roche #pharmapic.twitter.com/nKuVF6lxFm"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...